biomedicina slovenica


"GLYCOPROTEINS" : 111

  1. Zupančič Daša; Erdani-Kreft Mateja; Romih Rok
    Combined lectin- and immuno-histochemistry (CLIH) for fluorescence microscopy
    2023
  2. Gattinger Pia; Mittermann Irene; Lupinek Christian; Hofer Gerhard; Keller Walter; Bidovec Urška; Korošec Peter; Koessler Christine; Novak Natalija; Valenta Rudolf
    Recombinant glycoproteins resembling carbohydrate-specific IgE epitopes from plants, venoms and mites
    2019
  3. Zadražnik Tanja; Egge-Jacobsen Wolfgang; Šuštar Vozlič Jelka
    Analysis of glycoproteins in leaves of common bean (Phaseolus vulgaris L.) under drought
    2014
  4. Zadražnik Tanja; Egge-Jacobsen Wolfgang; Šuštar Vozlič Jelka
    Proteomics analysis of drought stress
    2014
  5. Kitanovski Lidija; Derganc Metka
    Napovedna vrednost lipopolisaharid vezujoče beljakovine za bakteriemijo in klinično sepso pri otrocih s febrilno nevtropenijo
    [Diagnostic accuracy of lipopolysaccharide binding protein for predicting bacteremia and clinical sepsis in children with febrile neutropenia]
    2014
  6. Petrovič Danijel
    Effects of environmental, genetic, and epigenetic factors on platelet glycoproteins and the development of diabetic retinopathy
    2014
  7. Zupančič Daša; Erdani-Kreft Mateja; Romih Rok
    Selective binding of lectins to normal and neoplastic urothelium in rat and mouse bladder carcinogenesis models
    2013
  8. Franko Alenka; Dolžan Vita; Kovač Viljem; Arnerić Niko; Dodič-Fikfak Metoda
    Soluble mesothelin-related peptides levels in patients with malignant mesothelioma
    2012
  9. Nikolajević-Starčević Jovana; Globočnik-Petrovič Mojca; Petrovič Danijel
    A1/A2 polymorphism of the glycoprotein IIIa gene and diabetic retinopathy in Caucasians with type 2 diabetes
    2011
  10. Lenasi Tina; Contreras Xavier; Peterlin Mitja B
    Transcriptional interference antagonizes proviral gene expression to promote HIV latency
    2008
  11. Lakota Katja; Žigon Polona; Mrak-Poljšak Katjuša; Rozman Blaž; Shoenfeld Yehuda; Sodin-Šemrl Snežna
    Antibodies against acute phase proteins and their functions in the pathogenesis of disease: a collective profile of 25 different antibodies
    2011
  12. Andreoli L; Nalli C; Motta M; Norman GL; Binder WL; Nuzzo M; Frassi M; Lojacono A; Avčin T; Meroni PL
    Sottopopolazioni di anticorpi anti-beta2glicoproteina I con diverso potenziale patogenetico: fine specificita` nei confronti dei domini della beta2glicoproteina I
    [Subpopulations of anti-beta2glycoprotein I antibodies with different pathogenic potential: fine specificity against the domains of beta2glycoprotein I]
    2010
  13. Nalli C; Andreoli L; Motta M; Norman GL; Shums Z; Binder WL; Nuzzo M; Frassi M; Lojacono A; Avčin T
    La fine specificita degli anticorpi anti-beta2 glicoproteina I nelle malattie autoimmuni sistemiche e prevalentemente diretta verso il dominio 1
    [Fine specificity of anti-beta2glycoprotein I antibodies in systemic autoimmune diseases is mostly directed against domain 1]
    2011
  14. Čučnik S; Kveder T; Ulcova-Gallova Z; Swadzba J; Musial J; Valesini G; Avčin T; Rozman B; Božič B
    Avidity of anti-beta2-glycoprotein I antibodies in patients with or without antiphospholipid syndrome: a collaborative study in the frame of the European forum on antiphospholipid antibodies
    2011
  15. Mittermann Irene; Zidarn Mihaela; Šilar Mira; Markovic-Housley Zora; Aberer Werner; Korošec Peter; Košnik Mitja; Valenta Rudolf
    Recombinant allergen-based IgE testing to distinguish bee and wasp allergy
    2010
  16. Švajger Urban; Vidmar Alenka; Jeras Matjaž
    Niflumic acid renders dendritic cells tolerogenic and up-regulates inhibitory molecules ILT3 and ILT4
    2008
  17. Frank Mojca; Sodin-Šemrl Snežna; Irman Špela; Božič Borut; Rozman Blaž
    Beta2-glycoprotein I and annexin A5 phospholipid interactions: artificial and cell membranes
    2009
  18. Chao Steven; Benowitz Larry I; Krainc Dimitri; Irwin Nina
    Use of a two-hybrid system to investigate molecular interactions of GAP-43
    1996
  19. Boffa Marie-Claire; Boinot Catherine; De Carolis Sara; Rovere-Querini Patrizia; Aurousseau Marie-Helene; Allegri Flavio; Nicaise-Roland Pascale; Ambrožič Aleš; Avčin Tadej
    Laboratory criteria of the obstetrical antiphospholipid syndrome: data from a multicentric prospective European women cohort
    2009
  20. Mayhew Terry M
    Stereology and some structural correlates of retinal and photoreceptor cell function
    2009
  21. Toplak N; Kveder T; Trampuš-Bakija A; Šubelj V; Čučnik S; Avčin T
    Autoimmune response following annual influenza vaccination in 92 apparently healthy adults
    2008
  22. Sodin-Šemrl Snežna; Rozman Blaž; Iglič Aleš; Kralj-Iglič Veronika
    Antiphospholipid syndrome: mechanisms revealed in erythrocyte and liposome studies
    2008
  23. Urbanija Jasna; Babnik Blaž; Frank Mojca; Tomšič Nejc; Rozman Blaž; Kralj-Iglič Veronika; Iglič Aleš
    Attachment of beta(2)-glycoprotein I to negatively charged liposomes may prevent the release of daughter vesicles from the parent membrane
    2008
  24. Lokar Maruša; Urbanija Jasna; Frank Mojca; Hagerstrand Henry; Rozman Blaž; Bobrowska-Hagerstrand Malgorzata; Iglič Aleš; Kralj-Iglič Veronika
    Agglutination of like-charged red blood cells induced by binding of beta(2)-glycoprotein I to outer cell surface
    2008
  25. Thangarajh Mathula; Masterman Thomas; Helgeland Lars; Rot Uroš; Jonsson Malin V; Egil-Eide Geir; Pirskanen Ritva; Hillert Jan; Jonsson Roland
    The thymus is a source of B-cell-survival factors-APRIL and BAFF-in myasthenia gravis
    2006
  26. Kirbiš Simona; Sinkovič Andreja
    Alveolar hemorrhage after treatment with glycoprotein IIb/IIIa inhibitors - case report
    2008
  27. Avčin Tadej; Cimaz Rolando
    Pediatric antiphospholipid syndrome
    2008
  28. Urbanija Jasna; Tomšič Nejc; Lokar Maruša; Ambrožič Aleš; Čučnik Saša; Rozman Blaž; Kandušer Maša; Iglič Aleš; Kralj-Iglič Veronika
    Coalescence of phospholipid membranes as a possible origin of anticoagulant effect of serum proteins
    2007
  29. Sodin-Šemrl S; Rozman B
    Beta2-glycoprotein I and its clinical significance: from gene sequence to protein levels
    2007
  30. Tomšič Nejc
    Vpliv kardiolipina in holesterola na lastnosti fosfolipidnih mehurčkov in njihove interakcije z okolno raztopino
    2006
  31. Erman A; Veranič P; Pšeničnik M; Jezernik K
    Superficial cell differentiation during embryonic and postnatal development of mouse urothelium
    2006
  32. Salobir Barbara; Šabovič Mišo; Hojnik Maja; Čučnik Saša; Kveder Tanja
    Anti-beta2-glycoprotein I antibodies of IgM class are linked to thrombotic disorders in young women without autoimmune disease
    2007
  33. Gašperšič N; Ambrožič A; Božič B; Majhenc J; Svetina S; Rozman B
    Annexin A5 binding to giant phospholipid vesicles is differentially affected by anti-beta2-glycoprotein I and anti-annexin A5 antibodies
    2007
  34. Lukač Janja; Čučnik Saša; Kveder Tanja; Strle Franc; Rozman Blaž
    Anti-beta2-glycoprotein I antibodies in Lyme borreliosis: differences in disease stage and immunoglobulin class distribution
    2006
  35. Pawlaczyk Mariola; Sobieska Magdalena
    A correlation between acute phase proteins and cytokines in patients suffering from mycosis fungoides
    2006
  36. Romih Rok; Erdani-Kreft Mateja; Jezernik Kristijan
    Changes of sugar residues in the apical plasma membrane during differentiation of superficial urothelial cells
    2006
  37. Avberšek-Lužnik Ivica; Pečovnik-Balon Breda; Rus Igor; Marc Janja
    Increased bone resorption in HD patients: is it caused by elevated RANKL synthesis?
    2005
  38. Pristovšek Primož; Simčič Saša; Wraber Branka; Urleb Uroš
    Structure of a synthetic fragment of the lipopolysaccharide (LPS) binding protein when bound to LPS and design of a peptidic LPS inhibitor
    2005
  39. Martinuč-Porobič J; Avčin T; Božič B; Kuhar M; Čučnik S; Zupančič M; Prosenc K; Kveder T; Rozman B
    Anti-phospholipid antibodies following vaccination with recombinant hepatitis B vaccine
    2005
  40. Božič Borut; Čučnik Saša; Kveder Tanja; Rozman Blaž
    Avidity of anti-beta2-glycoprotein 1 antibodies in patients with antiphospholipid syndrome
    2005
  41. Čučnik S; Božič B; Kveder T; Tomšič M; Rozman B
    Avidity of anti-beta2-glycoprotein I and thrombosis or pregnancy loss in patients with antiphospholipid syndrome
    2005
  42. Božič B; Čučnik S; Kveder T; Rozman B
    Avidity of anti-beta-2-glycoprotein I antibodies
    2005
  43. Ambrožič Aleš; Božič Borut; Kveder Tanja; Majhenc Janja; Arrigler Vesna; Svetina Saša; Rozman Blaž
    Budding, vesicular and permeabilization of phospholipid membranes-evidence for a feasible physiologic role of beta2-glycoprotein I and pathogenic actions of anti-beta2-glycoprotein I antibodies
    2005
  44. Ficko Tanja
    Opredelitev razvojnih stopenj megakariopeze s količinskim določanjem molekul mRNA za trombocitno specifične glikoproteine
    2005
  45. Potočnik U; Ferkolj I; Glavač D; Dean M
    Polymorphisms in multidrug resistance 1 (MDR1) gene are associated with refractory Crohn disease and ulcerative colitis
    2004
  46. Poglajen G; Kirbiš J; Milutinović A
    The -455G/A polymorphism of the beta fibrinogen gene and the Bgl II polymorphism of the alpha2beta1 integrin gene and myocardial infarction in patients with type 2 diabetes
    2004
  47. Čučnik Saša; Kveder Tanja; Ambrožič Aleš; Božič Borut
    High avidity antibodies against beta2-glycoprotein I
    [Visoko avidna protitelesa proti beta2-glikoproteinu I]
    2004
  48. Čučnik Saša; Kveder Tanja; Rozman Blaž; Božič Borut
    Isolation of beta2GPI by perchloric acid yields three protein peaks having different antigenic properties
    [Izolacija beta2GPI s perklorno kislino prinaša tri proteinske frakcije z različnimi antigenskimi lastnostmi]
    2004
  49. Ambrožič Aleš; Božič Borut; Čučnik Saša; Kveder Tanja; Rozman Blaž
    Prothrombin fragment 1+2 as a marker of hypercoagulable state in patients with antiphospholipid antibodies
    [Protrombinski fragment 1+2 kot označevalec hiperkoagulabilnega stanja pri bolnikih z antifosfolipidnimi protitelesi]
    2004
  50. Čučnik S; Kveder T; Rozman B; Božič B
    Binding of high-avidity anti-beta2-glycoprotein I antibodies
    2004
  51. Zagradišnik Boris; Bračič Katarina; Marčun-Varda Nataša; Kokalj-Vokač Nadja; Gregorič Alojz
    G-protein beta3 subunit gene C825T polymorphism in patients with vesico-ureteric reflux
    2004
  52. Ambrožič Aleš
    Lastnosti in mehanizmi trombogenega delovanja protiteles proti beta2-glikoproteinu 1
    2004
  53. Avčin T; Markelj G; Nikšič V; Rener-Primec Z; Čučnik S; Zupančič M; Rozman B; Neubauer D
    Estimation of antiphospholipid antibodies in a prospective longitudinal study of children with migraine
    2004
  54. Čučnik Saša
    Pomen avidnosti protiteles proti beta2-glikoproteinu I pri bolnikih s sistemskimi avtoimunskimi boleznimi
    [The importance of anti-beta2-glycoprotein I antibodies' avidity in patients with systemic autoimmune diseases]
    2004
  55. Ambrožič A; Kveder T; Božič B; Rozman B
    Comparison of different kits in the detection of autologous to cardiolipin and beta2-glycoprotein 1: comment on the article by Audrain et al.
    2004
  56. Pavčnik-Arnol Maja; Hojker Sergej; Derganc Metka
    Lipopolysaccharide-binding protein in critically ill neonates and children with suspected infection: comparison with procalcitonin, interleukin-6, and C-reactive protein
    2004
  57. Markelj Gašper; Nikšič Vesna
    Pomen in vloga antifosfolipidnih protiteles pri mladih z migrenskim glavobolom
    2003
  58. Čučnik Saša; Križaj Igor; Rozman Blaž; Kveder Tanja; Božič Borut
    Concomitant isolation of protein C inhibitor and unnicked beta2-glycoprotein I
    2004
  59. Avčin Tadej
    Podrobna specifičnost in pomen antifosfolipidnih protiteles v otroškem obdobju
    [The fine specificity and significance of antiphosholipid antibodies in pediatric populations]
    2003
  60. Hevener Andrea L; Reichart Donna; Janež Andrej; Olefsky Jerrold
    Thiazolidinedione treatment prevents free fatty acid-induced insulin resistance in male wistar rats
    2001
  61. Shoenfeld Y; Krause I; Kvapil F; Sulkes J; Lev S; von Landenberg P; Font J; Zaech J; Praprotnik S; Rozman B
    Prevalence and clinical correlations of antibodies against six beta2-glycoprotein-I-related peptides in the antiphospholipid syndrome
    2003
  62. Gašperšič N; Rot U; Čučnik S; Božič B; Kveder T; Rozman B
    Low prevalence of antiphospholipid antibodies in a series of young patients with cerebrovascular disease
    2003
  63. Gašperšič Nataša
    Aneksin V, kofaktor za antifosfolipidna protitelesa in njegova vloga pri bolnikih z ishemično možganskožilno boleznijo
    2003
  64. Meisel SR; Shimon I; Edgington TS; Melmed S; Čerček B; Shah PK
    Leukemia inhibitory factor enhances the expression of tissue factor protein and procoagulant activity in adherent human monocyte-derived macrophages: a gp 130-mediated mechanism
    1999
  65. Zahger D; Fishbein MC; Grafinkel LI; Shah PK; Forrester JS; Regnstrom J; Yano J; Čerček B
    VCL, an antagonist of the platelet PG1b receptor, markedly inhibits adhesion and intimal thickening following balloon injury in the rat
    1995
  66. Avberšek-Lužnik Ivica; Malešič Ivan; Rus Igor; Marc Janja
    Increased levels of osteoprotegerin in hemodialysis patients
    2002
  67. Rožman Primož
    Platelet antigens. The role of human platelet alloantigens (HPA) in blood transfusion and transplantation
    2002
  68. Rožman P; Karas M; Košir A; Labar B; Madrigal A; Middleton D; Navarrete C; Oudshoorn M; Schemmach H; Vitek A; Bohinjec M
    Are human platelet alloantigens (HPA) minor transplantation antigens in clinical bone marrow transplantation?
    2003
  69. Ambrožič Aleš; Avčin Tadej; Ichikawa Kenji; Kveder Tanja; Matsuura Eiji; Hojnik Maja; Atsumi Tatsuya; Rozman Blaž; Koike Takao
    Anti-beta(2)-glycoprotein I antibodies in children with atopic dermatitis
    2002
  70. Sherer Y; Tenenbaum A; Praprotnik S; Shemesh J; Blank M; Fisman EZ; Motro M; Shoenfeld Y
    Autoantibodies to cardiolipin and beta-2-glycoprotein-I in coronary artery disease patients with and without hypertension
    2002
  71. Romih R; Korošec P; Jezernik K; Sedmak B; Tršinar B; Deng FM; Liang FX; Sun TT
    Inverse expression of uroplakins and inducible nitric oxide synthase in the urothelium of patients with bladder outlet obstruction
    2003
  72. Tomažič Marjeta
    Prenos glukoze v adipocitih pri nosečnostni sladkorni bolezni
    2002
  73. Erdani-Kreft Mateja; Romih Rok; Sterle Maksimiljan
    Antigenic and ultrastructural markers associated with urothelial cytodifferentiation in primary explant outgrowths of mouse bladder
    2002
  74. Cimaz R; Romeo A; Scarano A; Avčin T; Viri M; Veggiotti P; Gatti A; Lodi M; Catelli L; Panzeri P
    Prevalence of anti-cardiolipin anti-beta2 glycoprotein I, and anti-prothrombin antibodies in young patients with epilepsy
    2002
  75. Salobir B; Šabovič M; Koželj M
    Increased levels of antiphospholipid antibodies in a woman with left atrial myxoma and systemic embolisms
    2001
  76. Josić Djuro; Schwinn Horst; Stadler M; Štrancar Aleš
    Purification of factor VIII and von Willebrand factor from human plasma by anion-exchange chromatography
    1994
  77. Costa Silvano; Terzano Patrizia; Bovicelli Alessandro; Martoni Andrea; Angelelli Bruna; Santini Donatella; Ceccarelli Claudio; Lipponen Pertti; Eržen Mojca; Syrjaenen Stina
    CD44 isoform 6 (CD44v6) is a prognostic indicator of the response to neoadjuvant chemotherapy in cervical carcinoma
    2001
  78. Manček Mateja; Pristovšek Primož; Jerala Roman
    Identification of LPS-binding peptide fragment of MD-2, a toll-receptor accessory protein
    2002
  79. Peng Michael M; Matos Olga; Gatei Wangeci; Das Pradeep; Stantic-Pavlinic Mirjana; Bern Caryn; Sulaiman Irshad M; Glaberman Scott; Lal Altaf A; Xiao Lihua
    A comparison of Cryptosporidium subgenotypes from several geographic regions
    2001
  80. Sherer Yaniv; Tenenbaum Alexander; Praprotnik Sonja; Shemesh Joseph; Blank Miri; Fisman Enrique Z; Harats Dror; George Jacob; Levy Yair; Peter James B
    Coronary artery disease but not coronary calcification is associated with elevated levels of cardiolipin, beta-2-glycoprotein-I, and oxidized LDL antibodies
    2001
  81. Juretić Dubravka; Krajnović Vera; Šepetavc Martina; Petlevski Roberta; Lukač-Bajalo Jana
    Glycosaminoglycans in the development and therapy of diabetic complications
    2001
  82. Avčin Tadej
    Antifosfolipidna protitelesa v serumih zdravih otrok in otrok z juvenilnim idiopatičnim artritisom
    2001
  83. Avčin T; Ambrožič A; Kuhar M; Kveder T; Rozman B
    Anticardiolipin and anti-beta2 glycoprotein 1 antibodies in sera of 61 apparently healthy children at regular preventive visits
    2001
  84. Skerjanec A; Sandler A; Green L; Marder P; Kuan S; Chaudhary A; Slapak C
    A phase I dose-escalating trial of LY335979, a potent multidrug-resistance modulator
    1999
  85. Sherer Yaniv; Shemesh Joseph; Tenenbaum Alexander; Praprotnik Sonja; Harats Dror; Fisman Enrique Z; Blank Miri; Motro Michael; Shoenfeld Yehuda
    Coronary calcium and anti-cardiolipin antibody are elevated in patients with typical chest pain
    2000
  86. Čučnik Saša
    Antifosfolipidna protitelesa pri trombozi, aterosklerozi in hipertenziji
    2000
  87. Grilc Sonja; Kuster Vlasta; Zorec Robert
    An RT-PCR analysis of synaptotagmins (I to VII) in rat parts intermedia cells
    2000
  88. Kain Renate; Ziebermayr Reinhard; Exner Markus; Fukuda Minoru; Kerjaschki Dontscho
    Incidence and specificity of antibodies to human lysosomal membrane protein 2 in focal necrotizing glomerulonephritis and systemic vasculitis
    1999
  89. Jereb Matjaž
    Diagnostična vloga prokalcitonina pri bolnikih z meningitisom
    1999
  90. Wraber Branka
    Citokini v kliniki - koristna informacija ali podatek odveč
    [Cytokines in clinical application - usefull or useless information]
    1998
  91. Wahl Sharon M; Wild Teresa K; Sanneman Thomas C; Janoff Edward N
    Mucosal inhibitors of HIV-1
    [Sluznični zaviralci virusa imunske pomanjkljivosti pri človeku (HIV-1)]
    1998
  92. George Jacob; Gilburd Boris; Hojnik Maja; Levy Yair; Langevitz Pnina; Matsuura Eiji; Koike Takao; Shoenfeld Yehuda
    Target recognition of Beta 2-glycoprotein I ( beta 2 GPI) - dependent anticardiolipin antibodies: evidence for involvement of the fourth domain of beta 2 GPI in antibody binding
    1998
  93. Bogataj Marija; Mrhar Aleš
    Bioadhezija
    [Bioadhesion]
    1998
  94. Kralj Jana
    Določanje antigenov CD62P in CD63 s pretočnim citometrom za oceno aktiviranih trombocitov
    [Detection of activated platelets by flow cytometric analysis of antigens CD62P and CD63]
    1998
  95. Romih Rok; Jezernik Kristijan; Mašera Andrej
    Uroplakins and cytokeratins in the regenerating rat urothelium after sodium saccharin treatment
    1998
  96. Hojnik Maja
    Imunogenost in patogenost različnih oblik beta2-glikoproteina I pri antifosfolipidnem sindromu
    [Immunogenicity and pathogenicity of different forms of beta2- glycoprotein I in the antiphospholipid syndrome]
    1997
  97. George Jacob; Blank Miri; Gilburd Boris; Hojnik Maya; Shenkman Boris; Tamarin Ilia; Varon David; Matsuura Eiji; Koike Takao; Shoenfeld Yehuda
    Immunologic characterization and functional properties of murine antibodies raised against deleted mutants of human beta2-glycoprotein I
    1997
  98. Rode B; Čufer T; Filipič B; Lacković G
    P-glycoprotein in adrenals of rabbits treated with cyclosporin A
    1996
  99. Čufer Tanja; Vrhovec Ivan; Škrk Janez; Šikić Branimir I
    Effect of cyclosporine A on serum cortisol levels in rabbits
    1996
  100. Grom J; Linde N; Klingeborn B
    Aujeszky's diseases virus antibodies detected by gE
    1995

1 101  



New search      Comments      Top of page Institute for Biostatistics and Medical Informatics